Thanks For Your Request. We Will Get Back You As Soon As Possible.
We commenced operations in 1995, and for over 3 decades, have built a legacy of expertize, experience and trust with patients, doctors and healthcare providers by conducting diagnostics tests, providing quality diagnosis and upgrading our technology in response to the changing customer needs. We were ranked second in terms of revenue from operations among diagnostic companies in India in Fiscal 2023 (Source: CRISIL Report). Our diagnostics laboratory network operates on a ‘hub-and-spoke’ model, whereby specimens are collected across multiple locations within an area or region for delivery/ shipment to our reference/ clinical laboratories for centralized diagnostics testing. Our GRL is located in Mumbai in Maharashtra and five RRLs are located in Gurugram in Haryana, Bengaluru in Karnataka, Chennai in Tamil Nadu, Kolkata in West Bengal and Cochin in Kerala, supported by 67 medium laboratories, 210 stat laboratories and 3,757 CTPs, as of March 31, 2023.
We offer a comprehensive test menu across pathology and radiology segments, with over 3,600 tests, as of March 31, 2023, comprising routine and specialized tests and have performed over 300.00 million tests since 2008. Our test menu includes: (i) pathology tests ranging from routine tests such as basic to esoteric tests in biochemistry, haematology, microbiology, genetics, immunology and clinical pathology; specialized tests such as advanced molecular diagnostics tests, including protein chemistry, cellular immunology, flowcytometry, genetics, cytogenetics, immunohistochemistry and advanced microbiology tests; and (ii) radiology tests ranging from routine tests such as basic echocardiograms, X-rays and ultrasounds; and specialized tests such as advanced radiology tests including MRI and CT. Our wellness services and preventive care health packages cater to different customer needs and preferences. We operate 25 wellness centers that provide comprehensive and holistic wellness and preventive healthcare services including pathology tests, radiology tests and certain other services such as audiometry, pulmonary function test, treadmill test, dexa scan, basic eye and dental check-up, physician consultation and gynaecologist consultation, as of March 31, 2023.
Our centralized information technology platform, CLIMS, enables: (a) automation of our laboratories, CTPs and other business processes; (b) seamless customer experience by centralizing the home visit bookings and allocations; and (c) seamless integration with other information technology systems. Further, the growth of our network is supported by the scalability of our technology platform, which can readily adapt to the increased data requirements of additional clinical laboratories and CTPs. We were also the first laboratory chain in India to integrate its own laboratory management system with Ayushman Bharat Digital Mission under the National Health Authority in Fiscal 2021.
Our technology infrastructure is supported by logistics efficiencies, such as route planning and optimization, integrated systems for registration (bar-coding), billing, analysis reporting and delivery of reports that enable us to reduce human error, deliver faster TAT and enhance customer experience. We are committed to delivering a customer-centric experience through an integrated and seamless customer experience enabled through our technology platforms and data-driven actionable insights. We have also implemented a WhatsApp Chat-bot feature for our patients to: (a) digitally book tests for home visit or lab visit; (b) retrieve lab reports; (c) locate nearest lab or collection center; and (d) address any other queries related to our service.
We have also recently partnered with a global image sharing platform for pathology that enables specialist pathologists at our reference laboratories to provide pathology consultation instantly on cases uploaded from remote locations in our laboratory network. We are committed to delivering a customer-centric experience through an integrated and seamless customer experience enabled through our technology platforms and data-driven actionable insights. We have also implemented a WhatsApp Chat-bot feature for our patients to: (a) digitally book tests for home visit or lab visit; (b) retrieve lab reports; (c) locate nearest lab or collection center; and (d) address any other queries related to our service. We have also received the “Patient Centricity for Diagnostic Labs” award at the IHW Patient First Awards 2022.
For over 28 years, we have established a pathology and radiology practice in India, offering quality and advanced diagnostics healthcare services. We had the largest NABL accredited network of laboratories in India, as of March 31, 2023. As of March 31, 2023, 43 of our laboratories have obtained accreditations from NABL in the field of medical testing. Three of our laboratories in India have also been recognized under “NABL Medical (Entry Level) Testing Labs ("NABL M(EL)T Labs") Program and our laboratories in Mumbai in Maharashtra and Dubai have also been accredited by CAP. Our laboratories were the first in India to have received accreditations from NABL and CAP in 1999 and 2002, respectively (Source: CRISIL report). Moreover, two of our laboratories in India are affiliated with the National Tuberculosis Elimination Programme (“NTEP”) for tuberculosis drug resistance testing.
We are focused on R&D to diagnose health concerns accurately and timely, and help patients and healthcare providers deal with various growing health ailments. Our R&D division seeks to identify new business areas including pharmacogenomics and preventive medicine, expand its existing test menu and develop new tests and assays in diagnostics, in order to improve sensitivity, specificity, time or costs as compared to available conventional tools. In particular, we focus on developing advanced solutions in diagnostics testing, laboratory efficiency and clinical decision support with a special focus on genomics and next-generation diagnostics. In Fiscal 2023, we introduced over 200 new tests including niche specialized tests such as ‘Tuberculosis Whole Genome Sequencing’, ‘Chromosomal Microarray’, ‘Complete Care Geno – Wellness’, ‘Dual Marker (FMF)’ by TRF Method and ‘Fatty Liver Index’. Further, our focus on specialized testing, particularly genomics, provides us with a significant competitive advantage. Moreover, our R&D division is ISO certified and has been recognized by the Department of Scientific and Industrial Research under the Government of India. We also operate three CoEs at Mumbai in Maharashtra and Gurugram in Haryana, as of March 31, 2023, which provide services in relation to histopathology (includes cancer diagnosis and second opinion cases), transplant immunology (includes tests related to solid organ transplant and hematopoietic stem cell transplant) and molecular pathology (includes both high-end genomic tests as well as complete molecular work-up of infectious diseases comprising viral, bacterial and parasitic infections).
Our R&D team also undertakes clinical research studies, co-marketing projects, contract evaluation and collaborations with various national laboratory network, technology providers and other advanced research centers on various areas with direct or indirect impact on healthcare. We regularly participate in scientific and academic conferences in India which has helped us in strengthening our brand recall and relationship with doctors. We are supported by a scientific team led by Dr. Avinash Phadke (President – Technical and Mentor, Clinical Pathology).
We derive benefit from the lineage of our Promoter, Fortis, by leveraging its long-standing legacy in healthcare services, in-depth understanding, and operational experience, in the healthcare industry, corporate governance standards, values and trust. Fortis is one of the leading players in the Indian healthcare delivery market in India in terms of revenue from operations in Fiscal 2023 (Source: CRISIL Report).
We have an experienced management team led by our Managing Director & Chief Executive Officer, Anand Kuppuswamy, who has over 25 years of experience in the healthcare industry. Anand Kuppuswamy was conferred with the “Healthcare CEO of the Year Award” in 2022. Our management team consists of professionals with skills in diagnostics and healthcare management, R&D, international business and finance, marketing and human resources. Our Board of Directors includes a combination of management executives and experts from the healthcare industry. The experience and diversity of our management team and Board of Directors give us the ability to operate successfully in our competitive industry and in the changing market environment, implement our strategies and successfully integrate any acquired businesses.
In our pursuit of expanding our diagnostic services beyond India, we have established a strong presence in Nepal. Our Mother Lab in Kathmandu serves as a central hub, providing advanced diagnostic services and leveraging our technological infrastructure to ensure accurate and timely results. Supported by our branch lab in Biratnagar, we are well-positioned to cater to the growing healthcare needs of the region. This expansion aligns with our vision to provide accessible, high-quality diagnostic services across South Asia, further strengthening our network and presence in the global diagnostics industry.